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Abstract
Background: Strategic, interdisciplinary partnerships are essential to addressing the complex drivers of health
inequities that result in survival disparities worldwide. Take for example the aggressive early childhood eye cancer
retinoblastoma, where survival reaches 97 % in resource-rich countries, but is as low 30 % in some resource-limited
nations, where 92 % of the burden lies. This suggests a need for a multifaceted approach to achieve a tangible and
sustainable increase in survival.
Methods: We assembled the history the Kenyan National Retinoblastoma Strategy (KNRbS), using information
documented in NGO reports, grant applications, news articles, meeting agendas and summaries. We evaluated the
KNRbS using the principles found in the guide for transboundary research partnerships developed by the Swiss
Commission for Research Partnerships with Developing Countries.
Results: A nationally co-ordinated approach drawing input and expertise from multiple disciplines and sectors presented
opportunities to optimise cure of children with retinoblastoma. Annual meetings were key to achieving the over 40 major
outputs of the group’s efforts, related to Awareness, Medical Care, Family Support and Resource Mobilization. Three
features were found to be critical to the KNRbS success: multidisciplinarity, consistency and flexibility.
Conclusion: The KNRbS has achieved a number of key outputs with limited financial investment. As a partnership, the
KNRbS meets most of the criteria identified for success. Challenges remain in securing the long-term sustainability of its
achievements. Elements of the Kenyan National Retinoblastoma Strategy may be useful to other developing countries
struggling with limited survival of retinoblastoma and other cancers or rare diseases.
Keywords: Multidisciplinary, Multisectoral, Partnership, Kenya, Retinoblastoma, Global health, Capacity building
Background
National strategies are a relatively recent innovation in
sustainable development. They mark a transition from a
fixed strategy towards an adaptive one that allows for con-
tinuous improvement [1]. National strategies have become
increasingly popular in addressing healthcare challenges.
It has been noted that a well-conceived, well-orchestrated
national strategy can reduce cancer incidence and im-
prove the quality of life for persons with cancer [2].
To be effective, a national strategy requires investment
and expertise from partners across multiple disciplines,
providing critical information on how best to deliver
healthcare, enact policy and effectively evaluate pro-
cesses. Partnerships between actors in resource-rich and
resource-limited nations which are mutually beneficial
are becoming increasingly common. Here we describe
an international, multidisciplinary partnership conceived
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to improve survival in Kenya from a rare, aggressive
childhood eye cancer, retinoblastoma.
An estimated 760 children are newly affected by
retinoblastoma annually in the 11 countries constituting
East Africa [3]. Outcomes for retinoblastoma in East
Africa have been poor, with survival estimated at 23 % in
2006 [4]. Kenya has a relatively large burden of children
with retinoblastoma and historically low levels of
survival, but also a group of individuals willing to work
together to improve care. These factors provided an im-
petus for developing the Kenyan National Retinoblastoma
Strategy (KNRbS), a multidisciplinary, multisectoral
partnership aimed at improving retinoblastoma outcomes
in Kenya.
Delivering optimal care for retinoblastoma is complex
and requires a multidisciplinary team. This team in-
cludes medical specialists, such as an ophthalmologist,
oncologist, pathologist and ideally a geneticist [5, 6]. The
medical specialists, in turn, rely on technical experts like
imaging specialists to be able to accurately diagnosis and
treat patients. Furthermore, social workers, child life
experts and genetic counsellors sensitively and accur-
ately disseminate information to a family affected by
retinoblastoma, which is critical for making the best
management choices. Assembling such a team is chal-
lenging in any situation, and particularly in low-resource
settings. Additional challenges to delivering best care for
patients with retinoblastoma include limited health-
seeking behaviour due to cultural factors or lack of
public awareness; socioeconomic barriers to healthcare
access; and weak or immature health care infrastructure
and health systems that limits availability of care [7, 8].
Increasingly, global efforts to improve retinoblastoma
survival are being made to address these various barriers
to care (reviewed in [9]).
In this article, we discuss the conception and im-
plementation of the KNRbS, and examine milestones
the group has achieved and challenges encountered.
More broadly, we explore how national strategies
may serve to improve cancer survival in resource-
limited countries.
Methods
Historical analysis
The history and goals of the Kenyan National Ret-
inoblastoma Strategy (KNRbS) were assembled using
information documented in NGO reports, grant
applications, news articles, meeting agendas and
summaries. The number, frequency, attendance, and
topics covered at annual KNRbS meetings were doc-
umented. Key activities and outputs were listed and
organized by relationship to overall goals of Aware-
ness, Medical Care, Family Support and Resource
Mobilization.
Conceptual framework
Several frameworks exist for the evaluation the success
of partnerships. We evaluated the KNRbS using the
principles found in the guide for transboundary research
partnerships developed by the Swiss Commission for Re-
search Partnerships with Developing Countries (KFPE)
[10]. The KFPE framework was developed specifically for
research partnerships. Although the goal of the KNRbS
strategy was not solely to expand research capacity, it was
recognized early on that solid data collection, and careful
measurement and application of the scientific method
would be key to evaluating impact, and thus research has
played a central role in its development.
Results
The KNRbS: a brief history
The creation of the KNRbS was driven by the knowledge
that survival from retinoblastoma is possible, and
buoyed by Daisy’s Eye Cancer Fund (DECF), an NGO
with the mandate to save lives and vision for children
affected by retinoblastoma. The discrepancy in retino-
blastoma survival between resource-rich and resource-
poor countries is highlighted by the event that spurred
DECF to focus on retinoblastoma in Sub-Saharan Africa.
As a baby, Rati was diagnosed with retinoblastoma in
her home country of Botswana and had the affected eye
removed at 11 months of age. Histopathological analysis
showed high-risk features necessitating further treat-
ment, however this report did not make it to the treating
physician in time. Rati developed cancer recurrence and
sought treatment in Canada, but ultimately died at age
four. Her death sparked the creation of Rati’s Challenge,
a major focus of DECF aimed at addressing poor retino-
blastoma survival in Sub-Saharan Africa [11].
The primary geographical focus for Rati’s Challenge
quickly became Kenya for several reasons. Kenya experi-
ences a significant number of new retinoblastoma cases
per year (~90), and Nairobi is a key ophthalmic hub in
East Africa. Crucially, the DECF team visited Kenya and
met with several highly motivated individuals that
shared their goals of increasing retinoblastoma survival
in East Africa [11].
Initial meetings in 2006 with Kenyan clinicians, retino-
blastoma survivors and community leaders indicated a de-
sire to create a formal national effort. In 2007, DECF
members visited four major retinoblastoma treatment cen-
tres in Kenya (Nairobi, Eldoret, Kisumu and Mombasa) and
met with various stakeholders, leading to the emergence of
the KNRbS group. The focus of this group was pri-
marily to create a national strategy to improve retino-
blastoma outcomes. The group also aimed to serve as
a template for the creation of national strategies in
neighbouring countries. A Kenyan chapter of DECF
was established and registered as an NGO in Nairobi
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to plan and execute activities related to the strategy. This
ensured the partnership was locally-led and locally-driven.
The KNRbS group
The membership of the KNRbS group is wide-ranging
and multidisciplinary. Members are united by their profes-
sional and/or personal commitment to retinoblastoma,
and include healthcare workers (e.g. ophthalmologists,
oncologists, nurses, ophthalmic clinical officers, child life
practitioners), academics (e.g. university professors, re-
searchers), retinoblastoma survivors and their families,
members of Kenyan government, and staff and board
members of DECF (Fig. 1). Most are Kenyan, hailing
from all over the country; few (~5) members are from
UK and Canada.
The membership was purposely designed to be multi-
disciplinary and multisectoral, to cultivate cross-talk and
collaboration to break through the barriers of traditional
‘silos’ most professions operate within. Members from
government agencies and DECF bring skills in diplo-
macy, partnership building, and outreach. Their involve-
ment promotes integration and sustainability of KNRbS
efforts to effect healthcare delivery. Complementing this,
members from academia and healthcare bring medical
expertise and strengths in research and evaluation.
Within the healthcare group, the involvement of individ-
uals from the multiple disciplines that provide retino-
blastoma care [5] promotes a comprehensive approach
to retinoblastoma management. Above all, the families
and retinoblastoma survivors remind the KNRbS group
that the central focus of all activities should remain on
the patient. They contribute their lived experience to
focus efforts on psychosocial challenges and basic
human rights of patients.
The KNRbS annual meetings
Injecting new ideas and fresh resolve, the lifeblood of
the National Strategy is the working meetings of the
KNRbS group. Since 2008, meetings have taken place
annually, lasting roughly three days each, and are hosted
in different Kenyan cities to facilitate participation from
members in different regions (Table 1).
While the first meeting aimed to critically assess and
document the retinoblastoma situation in Kenya and
identify challenges and solutions to be addressed (see
Situation analysis), subsequent meetings have functioned
by promoting critical reflection and discussion of activ-
ities, encouraging multidisciplinary collaboration by work-
ing in real time, and ensuring documentation of outcomes
and intended goals for the year ahead. A focus on meas-
urement, evaluation and research has helped the group
inch toward goals.
KNRbS members work in four thematic Task Forces:
Awareness, Medical Care, Family Support and Resource
Mobilization (Table 2). (For a thorough accounting of
the achievements of the KNRbS organized by Task
Fig. 1 KNRbS Membership. The KNRbS group (inner, light gray oval) is made up of a multidisciplinary team of academics (researchers, professors/
educators), members of healthcare teams (oncologists, ophthalmologists, nurses, pathologists, lab technicians, child life leaders, ophthalmic
clinical officers), government officials (Ministry of Medical Services, Department of Ophthalmic Services staff), staff and board members of Daisy’s
Eye Cancer Fund, retinoblastoma survivors and families. Communication and collaboration (grey arrows) between these groups allows for tangible
contributions towards improving retinoblastoma survival (black arrows). Through the KNRbS annual meetings, special ‘guests’ have attended and
participated on an ad-hoc basis (outer, dark gray oval), and have included members of Vision and Cancer NGOs, students participating on short-term
research projects, and visiting healthcare workers from East and West Africa
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Force, see Additional file 1: Table S1.) Specialty working
groups have arisen organically within these in order to
hone in on specific challenges (e.g. Pathology and Genet-
ics groups sprouted from Medical Care; a Child Life
group from Family Support). The activities within these
groups are fluid and may change each year as evidence
and experience grows and members learn what is effect-
ive and what is not.
The KNRbS group has benefited from the participa-
tion of ‘invited guests’ at the annual general meetings
(Table 1, Fig. 1). The contribution of these guests is to
provide training or to introduce a new perspective that
may help advance goals. Guests have included a repre-
sentative of the Kenya Cancer Association, who de-
scribed his group’s experience working with government
to introduce the Kenyan Cancer Bill; staff from a Kenyan
NGO with expertise in implementation of health policy;
and representatives from the University of Nairobi
Research Services office (Table 1). Occasionally students
from Canada and Kenya have joined the KNRbS meet-
ings to contribute to research and capacity building
efforts (Fig. 1).
In addition to attending the annual working meetings,
subsets of the group occasionally meet informally between
Table 1 Annual KNRbS Meetings and Outcomes
Meeting # Year Location # of days # of delegates Overall theme Primary aim(s) Invited speakers
1 2008 Nairobi 3 58 Planning • Identify current challenges
and priorities in retinoblastoma
management
2 2009 Mombasa 3 68 Planning • Create 5 year plan for KNRbS Ophthalmology Society
of East Africa: Access to
services for the blind
• Update on progress with respect
to 4 common challenges
• Discussion of national collaborative
laboratory pathology service (RbCoLab)
• Introduction to electronic medical
database (eCancerCare-Retinoblastoma)
3 2010 Nairobi 3 42 Capacity Building • Discussion of adoption of KNRbS
guidelines
Kenyan Cancer Association
(KENCASA): Kenya Cancer
Bill overview
• Focus on electronic medical database
4 2011 Mombasa 3 42 Capacity Building • Skills enhancement: surgical
techniques; child life practices
Anthropologist: Managing
cancer in a Kenyan Hospital
• Knowledge enhancement:
retinoblastoma genetics;
indications for chemotherapy;
grant writing
US Journalist: UN Summit
on Non Communicable
Diseases
Kenya Society for the Blind:
Coping with Blindness
5 2012 Nairobi 2 + 1
(workshop
preceding)
60 Capacity Building • Conference preceded by 1 day
clinical skills workshop
• Focus on long term sustainability
of KNRbS
• Discussion of the adoption of the
retinoblastoma guidelines
6 2013 Eldoret 2 + 1
(workshop
preceding)
80 Research, Innovation
& Implementation
• Conference preceded by 1 day
clinical skills workshop
Christian Blind Mission:
Implementation
of Guidelines
• Focus on retinoblastoma genetics
and pathology
East African Strategies -
Uganda, Ethiopia
• Discussion of logistics of guideline
implementation
7 2014 Nairobi 3 60 Research, Innovation
& Implementation
• Focus on research UoN Research Services
• Introduction to international
retinoblastoma group
(One RB World)
Technology: IT and
mobiles in health
services and management
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annual meetings to work towards agreed-upon goals.
However, communication between meetings for much of
the larger group has remained challenging, making the
annual meetings essential to progress for the KNRbS as a
whole. Administrative support and leadership from
DECF-K has been necessary for the organization and
hosting of the annual meetings.
The annual meetings were the only direct financial costs
of the KNRbS partnership. Costs of attendance were cov-
ered for all participants (venue, accommodation, modest
travel allowance). Grants and charitable donations (Add-
itional file 1: Table S1) were obtained to support the meet-
ings. The meetings also benefited from in-kind support
from KNRbS membership (e.g. DECF-K staff provided ad-
ministrative support and co-ordination; invited speakers
volunteered their time and expertise, etc.). Costs related to
the KNRbS achievements (next section) are considered
outputs in the context of this analysis, as their purpose
was not to directly support the KNRbS partnership.
KNRbS achievements
From a high-level perspective, the activities of the KNRbS
group have moved through 3 distinct stages: Planning,
Capacity Building, and Research and Innovation (Table 1).
We highlight key achievements here.
Situation analysis
Critical to the improvement of retinoblastoma outcomes
in East Africa is the identification of challenges to
survival, and resources available for retinoblastoma care.
A situation analysis was performed in the first meeting
of the KNRbS team in 2008 [12]. The major challenges
to the survival of affected children were identified as low
awareness, delayed referral, poor access to specialist care
and pathology, and lack of family support. Another chal-
lenge was identified in terms of resources required to
implement solutions. The challenges are listed by related
Task Force in Table 2. Immediate goals included the
development of a public awareness poster campaign, a
national retinoblastoma pathology service, agreed-upon
Best Practice Guidelines for Kenya, and training of
healthcare workers in Child Life practices. To raise
funds to support these programs, fundraising and appli-
cations to granting agencies were proposed.
National guidelines for retinoblastoma care
The publication of Kenyan National Retinoblastoma
Strategy Best Practices Guidelines represents a major
milestone reached by the KNRbS group in 2014
(Table 1). The Canadian National Retinoblastoma Strat-
egy Guidelines for Care [6] were used as a model and
adapted to the Kenyan context. Initially, each Task Force
aimed to produce specific document chapters, with a
large amount of work to be completed outside of the
annual meeting. However, the group met communica-
tion challenges, technological limitations, particularly for
collaborators in rural areas where Internet and com-
puters were not easily accessed, and other responsibil-
ities that distracted from this purpose. Instead, the
entire group worked on writing and editing the guide-
lines at each KNRbS annual meeting from 2008–2013
(Table 1). Although this method was likely more time
consuming, it ensured that all group members were able
to contribute to guideline development. Group consen-
sus on the guidelines was reached at the 2013 KNRbS
meeting. At the 2014 meeting, the published guidelines
were debuted by the Ministry of Health, and distributed
to all health clinics. They are freely available online [13].
Awareness
The KNRbS initiated many efforts to increase retinoblast-
oma awareness, with much support from NGO and gov-
ernment members of the group (Additional file 1: Table
S1). DECF-K published annual reports in the early years
of the project to inform the public of retinoblastoma facts
and figures and highlight KNRbS activities designed in re-
sponse. DECF-K was also instrumental in making connec-
tions with television, radio and print media outlets, which
Table 2 KNRbS Task Forces & Achievements
Focus group Challenge Solutions achieved (Selected)
Awareness • Low public awareness of retinoblastoma • Posters, Radio, TV, Print Media
• Low medical/healthcare professional awareness of retinoblastoma • Workshops, Maternal Child Health Booklet
Medical Care • Lack of data on retinoblastoma patient survival, referral, outcomes • Research
• Delayed referral of patients • Consensus Best Practice Guidelines, Research
• Poor availability of specialist care • Training, Consensus Best Practice Guidelines
• Delayed and inaccurate pathology • RbCoLab - Health Service Delivery Innovation
Family Support • Socioeconomic challenges in accessing healthcare • Cycle of Light
• Families have trouble coping with and understanding retinoblastoma • Child Life Training Program
Resource Mobilization • Little funding for programmatic support • Grants, Fundraisers
• Difficult to mobilize support and strategic partnerships for retinoblastoma • KNRbS meetings and invited guests
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ran stories featuring retinoblastoma patients and several
KNRbS efforts (Additional file 1: Table S1). A Swahili-
language retinoblastoma awareness poster designed by the
KNRbS Awareness taskforce and approved by the KNRbS
group was printed by DECF-K and distributed by the
Kenya Ministry of Health in clinics throughout the coun-
try. This information is also presented in the Kenyan Ma-
ternal and Child Health Booklet, a nationally distributed
paper record intended to track a child’s health and develop-
ment. Additional awareness activities included presenta-
tions at national and international conferences by KNRbS
members, and hosting retinoblastoma-themed rounds at
the home institutions of KNRbS members.
Family support
The KNRbS recognized immediately the need for sup-
portive care for families coping with a diagnosis of
retinoblastoma. Facilitating access to government subsi-
dized health insurance (National Health Insurance Fund,
NHIF) helped ease financial burden to indirectly assist
with meeting transportation and local accommodation
costs (see Research Mobilization). Anecdotal evidence
from physicians indicates this was accompanied by
increased treatment and follow-up compliance.
To address the transportation barrier directly, the
potential for a bus company to provide subsidized trans-
port for retinoblastoma-affected families was investigated.
However, companies were reluctant to commit due to
concern that they would be overwhelmed by the level of
need. Currently, small funds are provided to families for
transport when they cannot pay, funded by donations
from Kenyan community groups and individuals.
Another approach considered was the development of
family accommodation, “Kito House”. A document was
developed, detailing the needs of the planned facility. One
major challenge identified was the cost of land in Nairobi
and the practicality of transporting families from a site
outside the city centre, where land is more affordable but
transport more complex. Family Support task force mem-
bers made an onsite visit to a successful facility for fam-
ilies of cancer patients, “Ujasiri House” in Dar es Salaam,
Tanzania [14]. This house is funded by a nonprofit but is
built on the site of a public hospital, on land leased by the
hospital for 10 years. Meals and utilities are supplied and
funded by the hospital. The KNRbS team and the Kenya
Childhood Cancer Trust are now investigating the possi-
bility of developing a similar house on land belonging to
Kenyatta National Hospital in Nairobi. This requires care-
ful, long term planning, and will be a major focus of the
Family Support task force in the coming years.
Training
Several training endeavours have been initiated by the
KNRbS, both with an individual focus (fellowships) and
a group focus (workshops). Two KNRbS members were se-
lected for international fellowships in Ocular & Retino-
blastoma Pathology, and Clinical Retinoblastoma Practice,
respectively. Workshops were generally linked to the
KNRbS meetings (Table 1) to ensure optimal attendance
and reduce costs. Topics included retinoblastoma genetics,
myoconjunctival enucleation technique [15], introduction
to an electronic retinoblastoma care database (see eCancer-
Care-Retinoblastoma), ophthalmology and oncology for
retinoblastoma, grant writing and child life practices (Add-
itional file 1: Table S1). One workshop concerning hand-
ling and processing of eye specimens for pathology
technicians (Additional file 1: Table S1) took place outside
the regular KNRbS meeting schedule. This was because
the target participants fell outside the main KNRbS mem-
bership, yet their training was essential to the develop-
ment of the retinoblastoma pathology service (see The
Retinoblastoma Collaborative Laboratory - RbCoLab).
Training has extended to the collaborative supervision
of two graduate students at the University of Nairobi.
Supporting future researchers is an integral aspect of
building research capacity in Kenya.
Resource mobilization
Resources were mobilized in the form of grants, private
monetary and in-kind donations, and political support
(Additional file 1: Table S1). The first KNRbS meeting was
supported in part by a grant from the Canadian Institutes
for Health Research (CIHR). Reporting back to the CIHR
on this inaugural meeting provided a format for setting up
measurable outcomes, supporting a research approach.
Additional grant funds have been obtained since in
support of annual meetings, training and innovations
sprouting from the group. DECF has also experimented
with event fundraising to support KNRbS endeavours,
with modest success (Additional file 1: Table S1).
A rather innovative approach for alleviating the finan-
cial burden of care faced by families was a microfinance
program, ‘Cycle of Light’, developed by DECF-K (Add-
itional file 1: Table S1). Parents of inpatients with ret-
inoblastoma were taught to make handicrafts, which
were sold to cover costs associated with hospitalization,
namely NHIF premiums, additional treatment costs
and subsistence. The program was pilot-tested at Moi
Teaching and Referral Hospital and later introduced in
the eye ward of Kenyatta National Hospital. With more
families registered with NHIF, which covers inpatient
treatment, the financial burden of families associated
with treatment has been greatly reduced. Recently,
NHIF has been updated to cover the bulk of treatment
cost for pediatric cancers. This has lead to a shift in the
role of DECF-K and ‘Cycle of Light’ to increase aware-
ness of the existence of NHIF, ease the membership
process and assist parents in paying premiums.
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Research outputs
The KNRbS partnership has yielded 8 collaborative pub-
lications in peer-reviewed scientific journals (Additional
file 1: Table S1).
Basic, critical retinoblastoma information and insights
were collected at the onset of the KNRbS. Three-year
survival was found to be 26 % [16]. Probable causes for
low survival were identified: children in Kenya present
with late-stage retinoblastoma [17], and the time be-
tween initial diagnosis and treatment in a referral centre
is extensive, and children were lost to follow-up [18].
These baseline calculations will be used as comparison
statistics for follow-up research to determine the impact
of KNRbS efforts; the studies are currently under way.
A study led by members of the KNRbS genetics task
force (a sub-committee of the Medical Care Task Force)
identified a need to bolster retinoblastoma genetics edu-
cation amongst clinicians [19]. The difficulty in commu-
nicating complex genetic information is well-established,
yet effective dissemination of genetic information is crit-
ical for families to be able to make decisions in their best
interest, and to improve treatment compliance [20–22].
To address this, an interactive retinoblastoma genetics
workshop was designed with the aims of honing cancer
genetic counselling skills and improving knowledge of
retinoblastoma genetics, including diagnostics, amongst
clinicians [23]. Additional research publications in prep-
aration will document outcomes of health service deliv-
ery innovations in pathology and child life.
Health service delivery innovations
Four health service delivery innovations were piloted by
the KNRbS (Additional file 1: Table S1).
Enucleation technique & artificial eyes
Prior to the KNRbS, children who had an eye removed
(enucleation) for retinoblastoma did not receive an
implant, the purpose of which is to fill the resultant
empty space in the orbit, allow the fitting of a prosthetic
eye. This was partly due to a misconception held by
physicians that an implant could mask detection of
cancer recurrence. Moreover, without an implant, chil-
dren remain with an empty socket, facing stigmatization
and higher infection risk in the orbit. For these reasons,
parents found it difficult to accept enucleation even if it
was the only cure for their child.
The combination of surgical training provided at the
KNRbS meeting introduced the myoconjunctival enucle-
ation technique, which uses an inexpensive implant that
was first implemented and studied in India [15]. Train-
ing in Kenya helped dispel the misconception related to
masking of orbital recurrence, and coupled with the
availability of histopathology from the RbCoLab project
(see next section), physicians now had a more accurate
and powerful approach to predict children who were at
risk of recurrence.
Procurement of artificial eyes was another challenge
that was solved through coordinated efforts of DECF
and individual KNRbS members to purchase low-cost
prosthetics from India, and distribute them uniformly to
the clinics in the network. Now every child in Kenya can
look forward to an artificial eye if needed. This is an
example of a so-called ‘South-South’ innovation, as the
solution was adapted from another developing country.
The Retinoblastoma Collaborative Laboratory (RbCoLab)
When retinoblastoma is treated by enucleation, histo-
pathological analysis is essential in order to determine
the extent of tumor involvement in the eye. Tumor cells
evident in the optic nerve or sclera indicate a greater
probability that the tumor has escaped the eye, necessi-
tating further treatment for the child. However, too
often this important part of care is either unavailable, or
available and slow, incomplete or inaccurate.
The KNRbS group designed a system of centralized
pathology for retinoblastoma, called the Retinoblastoma
Collaborative Laboratory (RbCoLab) [24]. KNRbS meet-
ings were used to achieve consensus on pathology re-
quest and reporting forms. A pathologist was trained in
ocular and retinoblastoma pathology, and subsequent
training of pathologists and pathology technicians en-
sued (Additional file 1: Table S1). A specimen collection
kit was developed and distributed to eye units where ret-
inoblastoma enucleations were performed, and eyes
couriered to RbCoLab for processing. Reports with re-
sults were returned to physicians electronically, with
digital images of pathology slides available online. An
analysis of the impact of RbCoLab is forthcoming.
eCancerCare-Retinoblastoma
The KNRbS has tested the feasibility of implementing a
national retinoblastoma-specific electronic patient data-
base, eCancerCare-Retinoblastoma (eCCRB) [21, 22].
First developed in Canada, eCCRB is a point-of-care
medical record that documents patient demographics,
treatment and follow-up data using evidence-based
guidelines to inform data collection. A national medical
record for patients with retinoblastoma allows all doc-
tors in the patient’s circle of care to input and access
data, generating an instant, complete picture of patient
history and prognosis. In a student project, the KNRbS
first tested feasibility of using eCCRB use at multiple
retinoblastoma clinics, and offered feedback to Canadian
developers on adding data collection fields unique to
resource-limited settings. The updated Version 2.0 of
eCCRB was then hosted at the University of Nairobi on
a nationally accessible server, and user training took
place at KNRbS workshops. The group faced initial
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technical and logistical challenges implementing eCCRB,
including lack of network connectivity in some Operat-
ing Theatres, limiting the ability to enter data at point-
of-care. The group is currently creating work-arounds to
these challenges.
Child life program
Early in the development of the KNRbS, it was recog-
nized that Child Life, a strategy for helping children
cope with hospitalization and treatment [25], could dra-
matically improve care for children with retinoblastoma.
Child Life specialists provide psychosocial support and
medical education to children and their families, and use
simple techniques to help children cope with sometimes
traumatizing medical procedures. Child life programs
have positive psychological impacts on participants, and
can actually lower health care costs by reducing the dur-
ation of hospital stays and decreasing use of narcotics
for treatment [26]. In a resource-limited setting like
Kenya, this latter point becomes extremely relevant.
Child Life principles were introduced to the KNRbS
group through a series of annual lectures and practical
training sessions taking place the week prior to each
KNRbS meeting, led by a Canadian Certified Child Life
Specialist (CCLS) KNRbS member. Five KNRbS mem-
bers representing five key regions in Kenya (Coast,
Nairobi, Western, Rift Valley and Nyanza) were selected
for training as ‘Child Life Leaders’, and to introduce
Child Life practices through patient care in their home
institutions. The Sally Test Pediatric Center at Moi
Teaching & Referral Hospital in Eldoret hosted these
training sessions. In return, members of Moi staff were
invited to the training, effectively bringing child life to
Kenya beyond retinoblastoma alone. Child Life Leaders
kept logbooks of implementation of child life into their
daily professional practice, supervised and monitored by
their CCLS mentor. The combination of coursework and
experiential learning has prepared the trainees to meet
the eligibility requirements to write the Child Life Certi-
fication Exam, scheduled to take place in Eldoret in
September 2015. The will be the first certification exam-
ination to take place outside of North America, and
pending their success, the trainees will become the first
Certified Child Life Specialists in Kenya.
Discussion
We mapped the achievements of the KNRbS to the
KFPE framework (Table 3). The KNRbS fulfills 9/11
principles, with ongoing efforts to strengthen 2/11 prin-
ciples, namely principles (10) Apply Results and (11)
Secure Outcomes (Table 3).
With respect to (10) Apply Results, we have shown how
KNRbS activities have produced consensus national guide-
lines for care, and supported capacity-building initiatives
to facilitate their implementation. The group is on track
to evaluate the outcomes of their activities, such as effect
on availability, accessibility and quality of care, and ultim-
ately on patient survival at the national level. Assessing
barriers and facilitators to implementation will provide
information on reach and scalability of efforts, such that
no child is left behind (Table 3).
Moreover, Securing Outcomes (Principle 11) in the
long-term is necessary for sustained effect of KNRbS
activities on the care, survival and well-being of children
with retinoblastoma. For this principle, the KNRbS will
leverage partnerships within government and civil society
to sustain its impact (Table 3). One step in this direction
is the amalgamation of DECF-K within the Kenyan Child-
hood Cancer Trust (KCCT), an organization devoted to
improving care and survival for all pediatric cancers.
Inspired by the KNRbS national strategy approach, the
KCCT will learn from the retinoblastoma experience and
effect similar impact on other childhood cancers.
We noted 3 key features of the KNRbS partnership
that were essential to produce the results we observed:
1) Multidisciplinarity, 2) Consistency, and 3) Flexibility.
The integration of multiple, distinct disciplines into
the KNRbS group made many key initiatives possible by
leveraging disparate skills and expertise. This included
administrative and diplomacy strengths from DECF
members; scientific expertise for experimentation and
measurement of outcomes; academic expertise for the
design and delivery of training programs; medical and
psychosocial care expertise for innovation in healthcare
delivery; and the lived experience of retinoblastoma,
which influenced all spheres of KNRbS work, and united
members to a common purpose. The definition of global
health, as a discipline, has a focus on issues of health
equity with a multidisciplinary approach [22].
A major challenge of working within a multidisciplin-
ary team such as the KNRbS however, is the inevitable
conflict that arises based on discipline-specific biases
[21]. Although the KNRbS agenda and overarching goals
were established collectively as a group, the approaches
suggested to meet those goals varied widely between
disciplines. For example, civil society members were
more prone to supporting business-minded principles in
program design, in contrast to researcher members who
valued unstructured tinkering and experimentation.
The consistency of annual meetings ensured a depend-
able forum to openly discuss different perspectives, and
work towards building consensus on solutions. The
regular interactions helped build trust among group
members, and elicit personal investment and account-
ability in KNRbS efforts. While the group still faces
barriers in working together (for example, the institu-
tional barriers that may preclude a national approach for
some projects), the consistency of the meeting ensures
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Table 3 Evaluation of the KNRbS by Swiss Commission Principles on Effective International Research Partnerships
Recommendations (KFPE) Achieved? Evidence of Achievement Challenges
1. Set The Agenda Together Yes The Situation Analysis performed at the first
meeting with the involvement of the entire
group highlighted immediate priorities of
the strategy and agenda-setting.
Multidisciplinary group has different viewpoints;
although agenda is mutually agreed-upon, there
may be conflict in the approach to be used.
2. Interact with Stakeholders Yes KNRbS meetings are multidisciplinary and
include members from multiple sectors.
Establishing a partnership required time; needed
to build trust and delineate mutual benefit.
3. Clarify Responsibilities Yes Roles and responsibilities are set at KNRbS
meetings in person.
Communication challenges outside of the meeting
made it difficult to follow-up with roles &
responsibilities of members.
4. Account to Beneficiaries Yes Survivors & retinoblastoma families are part
of the KNRbS group. They serve as moral
‘compass’ to keep KNRbS on track to achieve
targets for the benefit of patients, and provide
lived experience to influence health
service delivery.
Multidisciplinary collaboration is difficult, particularly
between lay people and science/medical teams.
5. Promote Mutual Learning Yes Multiple workshops and learning opportunities
have been offered.
Fellowship funding is limited, yet fellowships
provide most intensive form of training.
Invited speakers that bring different perspectives
to the group; promotes cross-talk between
people with differing areas of expertise.
6. Enhance Capacities Yes Progress made in training, access to equipment,
and developing research capacities.
Different stakeholders had differing expectations for
the focus of capacity building, which required a
need to clarify priorities.
7. Share Data and Networks Yes An interconnected Kenyan referral system for
patients has been established.
Case studies from collaborating centers
discussed at KNRbS meetings
Skills & resources are not always evenly distributed
during early capacity building initiatives. For
example, most patients are treated in Nairobi,
whereas child life initiatives have been developed
in Eldoret.
Informal communication between participants
has strengthened relationships and resulted
in research collaborations.
8. Disseminate Results Yes Results have been disseminated via publications,
conferences, and awareness materials and media.
Participation at international meetings difficult due
to limited funding.
Consensus guidelines have been produced
and made available to all Kenyan professionals,
and online.
9. Pool profits and merits Yes Many grant applications were successfully funded. Few funding sources are available in Kenya.
Research is increasingly conducted by Kenyan
investigators and trainees.
Under-developed infrastructure for receiving
grants in Kenya keeps group dependent on
foreign partners.
There is a transparent system of authorship
on publications.
10. Apply Results Yes - ongoing Health service delivery innovations are being
pilot tested.
Funding limited to support these initiatives; need
to consider innovative approaches to ensuring
sustainability of efforts.
An assessment of barriers to successful
implementation performed; facilitators
of implementation identified.
11. Secure Outcomes Yes - ongoing Partnership with civil society and government
is intended to secure the sustainability of
the gains in retinoblastoma outcomes.
Establishing partnerships required time; needed
to build trust and delineate mutual benefit.
Endorsement of KNRbS guidelines by Kenyan
Ministry of Health validates recommendations.
Progress undermined by changes in political
stability, university and public hospital strikes, etc.
Securing outcomes for retinoblastoma requires
showing relevance of KNRbS approach to other
childhood cancers.
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that a forum exists in which to discuss these barriers
and explore plausible solutions.
Consistency in the KNRbS has been especially crucial
in the success of coordinating this sizable, geographically
dispersed and diverse team. The KNRbS was conceived
as a national strategy, which stems naturally from the
multidisciplinary, Kenya-wide expertise required for best
care for retinoblastoma (for example, while enucleations
can be performed at several secondary treatment cen-
ters, radiotherapy and focal therapy are only available at
one teaching hospital [18]). However, orchestrating a
coherent national strategy from inception has presented
logistical challenges including several mentioned pre-
viously (eg. technical and communication challenges).
Coordination of national strategies with local initiatives
was identified as a key challenge in the strategic manage-
ment of national strategies [27]. These difficulties have
been largely offset with an exquisite balance of consistency
and dependability from the annual meeting.
Finally, the third key element contributing to the
success of the KNRbS is flexibility. The evolution of core
focus from capacity building to research and innovation
demonstrates this ideal. Flexibility is evident in the
changing timelines and approaches in producing Best
Practice Guidelines and the current focus of the group
on addressing challenges with implementing eCCRB. In
addition, flexibility was key for the Cycle of Light pro-
gram: when circumstances changed such that families
could readily access NHIF, a shift in focus from aiming
to pay for treatment to facilitating NHIF registration
occurred. However the lessons learned from the pro-
gram, working with patients, and connections made in
the hospital beyond just the KNRbS, reaped benefits that
were re-invested into new KNRbS endeavors.
The achievements of the KNRbS have been facilitated
by key technological advancements. For example, RbCo-
Lab has permitted access to accurate pathology for
retinoblastoma cases in disparate locations where a
retinoblastoma-specialized pathologist is not available.
Accurate pathology is necessary for successful retino-
blastoma treatment, yet the number of pathologists in
Kenya is acutely limited [24]. The ability to rapidly
communicate findings electronically is critical for timely
retinoblastoma treatment. Similarly, connectivity is cen-
tral to eCCRb, which will organize and ease access to
patient data nationwide. The crux of the benefits of
technology is that it has permitted the communication
and organization of retinoblastoma management over
vast distances nearly immediately.
The KNRbS group has achieved a number of key outputs
with relatively little financial investment from its inception.
This underscores the value of having a committed group
with a shared vision, despite having few financial resources.
Progress has been made incrementally, with each success
setting the stage for growth. The achievements of the
KNRbS group speak to the value of the intellectual capital
provided by multidisciplinary networks such as this.
Next steps
Currently in the Innovation, Research, and Implementa-
tion Phase, efforts of the KNRbS will focus on imple-
menting results and securing their effects for maximum
sustainability of the program. Long-term patient out-
comes will be studied at the national level in Kenya.
Within greater East Africa, the KNRbS has inspired
national strategies in Uganda and Ethiopia. Delegates
from these countries have attended past KNRbS meet-
ings, and have hosted their own national retinoblastoma
meetings with guidance from KNRbS since 2013.
The KNRbS group will continue to be dynamic. For
example, the KNRbS NGO partners are evolving in their
roles. DECF has rebranded itself as World Eye Cancer
Hope, retaining its mission to save vision and lives globally,
but using the experiences from Kenya, Canada, US and UK
to guide its work on a broader international scale. The
Kenyan chapter of DECF, now absorbed by the KCCT, will
guide the application of the national strategy approach
improve survival from other pediatric cancers, using the
lessons learned from retinoblastoma in Kenya as a model.
Conclusions
The KNRbS was initiated in Kenya in 2008 in response
to the poor outcomes for children with an otherwise
curable eye cancer. Knowledge that optimal care re-
quired a multidisciplinary approach influenced the mem-
bership of the group. Although resource mobilization
was essential, it was not the overarching focus of the
group, and a large number of outputs was achieved with
careful design, leveraging of skills and networks of
multisectoral members.
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